Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
Completed · Phase 2
Conditions studied: Tobacco Use Disorder, Schizophrenia
In brief
This project tests two hypotheses concerning the low smoking cessation rates in smokers with schizophrenia. The first hypothesis is that smokers with schizophrenia experience stronger and more sustained effects of smoking abstinence on negative mood and smoking urge than control smokers without psychiatric illness. The second hypothesis is that smokers with schizophrenia experience stronger reinforcing effects of a smoking lapse (i.e., more rewarding effects of smoking after a period of abstinence) than control smokers without psychiatric illness.
Key facts
- Study ID
- NCT01214005
- Run by
- Brown University
- People needed
- 60
- Starts
- 2009-06-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2012-04-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- cigarette smokers, 20-50 cigarettes per day
- schizophrenia or no psychiatric illness
- age 18 or older
- male or female
You may not qualify if…
- unstable symptoms or medication
- not interested in quitting smoking within 6 months
Where it is running
- Brown University, 121 South Main Street — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.